Cuts, ousters and drama at the FDA

Turmoil, job cuts and forced ousters of high-ranking officials at federal health agencies. Marty Makary’s rough first week as FDA Commissioner. Biotech stocks tumble even further. President Trump’s “Liberation Day” tariffs roil global markets.

We talk about biotech’s volatile week, plus interview AstraZeneca R&D executive Sharon Barr, on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast.